The powerful science of RNA continues to generate a wealth of new biological opportunities that represent new approaches for innovative medicines. Just in the past year, multiple important new discoveries in this exciting field of biology have revealed additional possibilities to target a wide range of human diseases with novel and broadly acting treatments, including micoRNAs and RNAa. These are powerful new mechanisms with the potential for new ways to fight many diseases. The companies involved in this panel represent newer and more established biotechs who are evolving their businesses to capitalize on the drug discovery potential of these RNA mechanisms.

• Provide an overview on RNA and these subset approaches
• Review the biology around each RNA approach
• Discuss the publications/data to date and the development status of programs/candidates